Hana Golding
Division of viral products
CBER, Food and Drug Administration
Bethesda
USA
Name/email consistency: high
- CCR5 N-terminal region plays a critical role in HIV-1 inhibition by Toxoplasma gondii-derived cyclophilin-18. Golding, H., Khurana, S., Yarovinsky, F., King, L.R., Abdoulaeva, G., Antonsson, L., Owman, C., Platt, E.J., Kabat, D., Andersen, J.F., Sher, A. J. Biol. Chem. (2005)
- Inhibition of HIV-1 infection by a CCR5-binding cyclophilin from Toxoplasma gondii. Golding, H., Aliberti, J., King, L.R., Manischewitz, J., Andersen, J., Valenzuela, J., Landau, N.R., Sher, A. Blood (2003)
- Dissection of human immunodeficiency virus type 1 entry with neutralizing antibodies to gp41 fusion intermediates. Golding, H., Zaitseva, M., de Rosny, E., King, L.R., Manischewitz, J., Sidorov, I., Gorny, M.K., Zolla-Pazner, S., Dimitrov, D.S., Weiss, C.D. J. Virol. (2002)
- Increased association of glycoprotein 120-CD4 with HIV type 1 coreceptors in the presence of complex-enhanced anti-CD4 monoclonal antibodies. Golding, H., Ouyang, J., Zaitseva, M., Broder, C.C., Dimitrov, D.S., Lapham, C. AIDS Res. Hum. Retroviruses (1999)